Shibani Nicum
- Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer
2024/01/20 by Shibani Nicum, Naomi McGregor, Rachel Austin +16 · 13 citations
Medicine · #PARP inhibition in cancer therapy #Ovarian cancer diagnosis and treatment #Reproductive Biology and Fertility